Biodistribution, Tumor Detection, and Radiation Dosimetry of 18F-5-Fluoro-2'-Deoxycytidine with Tetrahydrouridine in Solid Tumors.

MLA

Young, Colin R., et al. “Biodistribution, Tumor Detection, and Radiation Dosimetry of 18F-5-Fluoro-2’-Deoxycytidine with Tetrahydrouridine in Solid Tumors.” Journal of Nuclear Medicine, vol. 60, no. 4, Apr. 2019, pp. 492–96. EBSCOhost, https://doi.org/10.2967/jnumed.118.216994.

APA

Young, C. R., Adler, S., Eary, J. F., Lindenberg, M. L., Jacobs, P. M., Collins, J., Kummar, S., Kurdziel, K. A., Choyke, P. L., & Mena, E. (2019). Biodistribution, Tumor Detection, and Radiation Dosimetry of 18F-5-Fluoro-2’-Deoxycytidine with Tetrahydrouridine in Solid Tumors. Journal of Nuclear Medicine, 60(4), 492–496. https://doi.org/10.2967/jnumed.118.216994

Chicago

Young, Colin R., Stephen Adler, Janet F. Eary, M. Liza Lindenberg, Paula M. Jacobs, Jerry Collins, Shivaani Kummar, Karen A. Kurdziel, Peter L. Choyke, and Esther Mena. 2019. “Biodistribution, Tumor Detection, and Radiation Dosimetry of 18F-5-Fluoro-2’-Deoxycytidine with Tetrahydrouridine in Solid Tumors.” Journal of Nuclear Medicine 60 (4): 492–96. doi:10.2967/jnumed.118.216994.